参考文献/References:
[1] 施惠华.高血压发病危险因素的性别差异研究[J].现代检验医学杂志,2013,28(3):95-98.
Shi HH.Gender differences in risk factor of hypertension[J].J Mod Lab Med,2013,28(3):95-98.
[2] 赵晓丽,胡大春,邵剑春,等.云南汉族健康人群6个原发性高血压候选基因多态性分布[J].现代检验医学杂志,2009,24(2):99-101.
Zhao XL,Hu DC,Shao JC,et al.[J].J Mod Lab Med,2009,24(2):99-101.
[3] Li JJ,Fang CH,Hui RT.Is hypertension an inflammatory disease?[J].Medical Hypotheses,2005,64(2):236-240.
[4] Nakajima T,Ota N,Yoshida H,et al.Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women[J].Genes Immun,1999,1(2):115-119.
[5] Conen D,Cheng S,Steiner LL,et al.Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension:theWomen's Genome Health Study[J].J Hypertens,2009,27(3):476-483.
[6] 伍松姣,梁景云,张景宇.正常高值血压人群血清C反应蛋白水平分析[J].现代检验医学杂志,2008,23(5):95-96.
Wu SJ,Liang JY,Zhang JY.Analysis of C Reactive protein level in the crowd with prehypertensive[J].J Mod Lab Med,2008,23(5):95-96.
[7] Wang L,Manson JE,Gaziano JM,et al.Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women[J].Clinical Chemistry,2011,57(5):729-736.
[8] Sesso HD,Wang L,Buring JE,et al.Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women[J].Hypertension,2007,49(2):304-310.
[9] 吕晓莉,程 功,任健康,等.自发性高血压大鼠药物干预后血清炎症因子变化及其对血管重塑的影响[J].现代检验医学杂志,2011,26(5):82-83,86.
L(¨overu)XL,Cheng G,Ren JK,et al.Effect of atorvastatin on serum inflammatory factors in spontaneously hypertersive rats[J].J Mod Lab Med,2011,26(5):82-83,86.
[10] Karaman E,Urhan Kucuk M,Bayramoglu A,et al.Investigation ofrelationship between IL-6 gene variants and hypertension in Turkish population[J].Cytotechnology,2015,67(6):947-954.
[11] 付海霞,张嘉莹,赵子牛,等.白细胞介素-6基因多态性及血清水平与原发性高血压的关系[J].第三军医大学学报,2007,29(18):1797-1800.
Fu HX,Zhang JY,Zhao ZN,et al.Relationship of interleukin-6 gene polymorphisms and its serum level with essential hypertension[J].Acta Academiae Medicinae Milituris Tertiae,2007,29(18):1797-1800.
[12] Wong LY,Leung RY,Ong KL,et al.Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension[J].J Hum Hypertens,2007,21(11):875-882.
[13] Jeng JR,Wang JH,Liu WS,et al.Association of interleukin-6 gene G-174C polymorphism and plasma plasminogen activator inhibitor-1 level in Chinesepatients with and without hypertension[J].Am J Hypertens,2005,18(4 Pt 1):517-522.
[14] 付海霞,李 艳,李庚山,等.白细胞介素-6基因多态性与原发性高血压的关系[J].临床心血管病杂志,2003,19(12):714-716.
Fu HX,Li Y,Li GS,et al.Association between interleukin-6 gene polymorphisms and primary hypertension in Hubei Han population[J].J Clin Cardiol(China),2003,19(12):714-716.
[15] Pola R,Flex A,Gaetani E,et al.The -174 G/C polymorphism of the interleukin-6 gene promoter and essential hypertension in an elderly Italian population[J].J Hum Hypertens,2002,16(9):637-640.
[16] Jenny NS,Tracy RP,Ogg MS,et al.In the elderly,interleukin-6 plasmalevels and the -174G>C polymorphism are associated with the development of cardiovascular disease[J].Arteriosclerosis Thrombosis and Vascular Biology,2002,22(12):2066-2071.
[17] Humphries SE,Luong LA,Ogg MS,et al.The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolicblood pressure in healthy men[J].European Heart Journal,2001,22(24):2243-2252.
[18] Tonet AC,Karnikowski M,Moraes CF,et al.Association between the -174G/C promoter polymorphism of the interleukin-6 gene and cardiovascular diseaserisk factors in Brazilian older women[J].Braz J Med Biol Res,2008,41(1):47-53.
[19] Rivera-Chavez FA,Peters-Hybki DL,Barber RC,et al.Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses[J].Shock(Augusta,Ga),2003,20(3): 218-223.
相似文献/References:
[1]赵 佳a,左 林b,姚创利a,等.锰超氧化物歧化酶基因变异
与血脂和同型半胱氨酸水平的关系研究[J].现代检验医学杂志,2016,31(03):12.[doi:10.3969/j.issn.1671-7414.2016.03.004]
ZHAO Jiaa,ZUO Linb,YAO Chuang-lia,et al.Study on the Relationship between Manganese Superoxide Dismutase
Gene Variants and the Levels of Blood Lipid and Homocysteine[J].Journal of Modern Laboratory Medicine,2016,31(01):12.[doi:10.3969/j.issn.1671-7414.2016.03.004]
[2]韩瑞玲,李 艳,吴 薇.武汉地区冠心病患者氯吡格雷药物代谢相关基因CYP2C19的多态性分布分析[J].现代检验医学杂志,2015,30(03):21.[doi:10.3969/j.issn.1671-7414.2015.03.006]
HAN Rui-ling,LI Yan,WU Wei.Analysis of the Polymorphism Distribution of Clopidogrel Metabolism
Related Gene CYP2C19 in Patients with Coronary Artery Disease in Wuhan[J].Journal of Modern Laboratory Medicine,2015,30(01):21.[doi:10.3969/j.issn.1671-7414.2015.03.006]
[3]王欣俞,王德辉,刘淑娟,等.中国汉族人群CYP2C9和VKORC1基因多态性对华法林用药的影响[J].现代检验医学杂志,2015,30(04):28.[doi:10.3969/j.issn.1671-7414.2015.04.007]
[4]刘运端,林世恒.脂联素及其基因多态性与广西瑶族冠心病的关系[J].现代检验医学杂志,2015,30(04):56.[doi:10.3969/j.issn.1671-7414.2015.04.015]
LIU Yun-duan,LIN Shi-heng.Study on Relations between Adiponectin and Its Gene
Polymorphism and Yao Coronary Heart Disease of Guangxi District[J].Journal of Modern Laboratory Medicine,2015,30(01):56.[doi:10.3969/j.issn.1671-7414.2015.04.015]
[5]姚创利a,赵 佳a,黎 阳a,等.锰超氧化物歧化酶9 Ala/Val基因多态性对冠心病的影响[J].现代检验医学杂志,2015,30(02):1.[doi:10.3969/j.issn.1671-7414.2015.02.001]
YAO Chuang-lia,ZHAO Jiaa,LI Yanga,et al.Effects of Manganese Superoxide Dismutase 9 Ala/Val
Genetic Polymorphisms on Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2015,30(01):1.[doi:10.3969/j.issn.1671-7414.2015.02.001]
[6]熊 娟,丁 园,张 敬,等.XRCC2基因R188H位点多态性与大肠癌易感性的Meta分析[J].现代检验医学杂志,2016,31(04):70.[doi:10.3969/j.issn.16717-414.2016.04.018]
XIONG Juan,DING Yuan,ZHANG Jing,et al.Association between XRCC2 R188H Polymorphism
and Risk of Colorectal Cancer:A Meta-Analysis[J].Journal of Modern Laboratory Medicine,2016,31(01):70.[doi:10.3969/j.issn.16717-414.2016.04.018]
[7]陈建国.结直肠癌患者FOLFOX化疗与GSTP1,XRCC1基因多态性的研究[J].现代检验医学杂志,2016,31(05):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
CHEN Jian-guo.Relationship between FOLFOX Chemotherapy of Colorectal Cancer
Patients and GSTP1,XRCC1 Gene Polymorphism[J].Journal of Modern Laboratory Medicine,2016,31(01):66.[doi:10.3969/j.issn.1671-7414.2016.05.017]
[8]姚创利,赵 佳,鲁旭娟,等.冠心病患者血清脂蛋白相关磷脂酶A2水平与锰超氧化物歧化酶9 Ala/Val基因多态性关系探讨[J].现代检验医学杂志,2017,32(01):26.[doi:10.3969/j.issn.1671-7414.2017.01.008]
YAO Chuang-li,ZHAO Ja,LU Xu-juan,et al.Study on the Relationship between Lipoprotein Associated
Phospholipase A2 Level and Manganese Superoxide Dismutase 9 Ala/Val
Genetic Polymorphism in Patients with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2017,32(01):26.[doi:10.3969/j.issn.1671-7414.2017.01.008]
[9]陈 文,朱旭明.血管紧张素转化酶插入/缺失基因多态性与抗高血压药疗效关系的meta分析[J].现代检验医学杂志,2017,32(02):67.[doi:10.3969/j.issn.1671-7414.2017.02.018]
CHEN Wen,ZHU Xu-ming.Association of Polymorphism
in Angiotensin Converting Enzyme Insertion/Deletion Gene
with Curative Effect of Hypotensive Drugs:A Meta Analysis[J].Journal of Modern Laboratory Medicine,2017,32(01):67.[doi:10.3969/j.issn.1671-7414.2017.02.018]
[10]张宝华a,武 琪b.Nrf2基因启动子rs35652124,rs6706649和rs6721961位点单核苷酸多态性与阿尔茨海默病的相关性研究[J].现代检验医学杂志,2017,32(05):62.[doi:10.3969/j.issn.1671-7414.2017.05.017]
ZHANG Bao-huaa,WU Qib.Association between Nrf2 Gene rs35652124,rs6706649
and rs6721961 Polymorphism and Alzheimer's Disease[J].Journal of Modern Laboratory Medicine,2017,32(01):62.[doi:10.3969/j.issn.1671-7414.2017.05.017]